ASTH (NASDAQ: ASTH) reported Q2 EPS of $0.19, $0.16 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $654.8 million versus the consensus estimate of $639.1 million.

GUIDANCE:

ASTH sees Q3 2025 revenue of $925-965 million, versus the consensus of $943.7 million.

ASTH sees FY2025 revenue of $3.1-3.3 billion, versus the consensus of $3.18 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.